Theralase Reports Complete Response in Bladder Cancer Preclinical Study

Theralase has reported a complete response with its X-Ray-Activated Rutherrin(R) in a preclinical study for muscle-invasive bladder cancer. This finding suggests a promising new treatment approach for the disease.

13 Apr, 11:16 — 13 Apr, 11:16

Post Share

Sources

Showing 1 of 1 sources

globe-and-mailHigh141d ago

Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study - The Globe and Mail

Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study The Globe and Mail

Read full article →

Theralase Reports Complete Response in Bladder Cancer Preclinical Study

Sources

Theralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study - The Globe and Mail

Related Stories

Joint Sino-Egyptian Mission Uncovers Ancient Relics at Memphis Site

UN Report Confirms Global Warming Will Exceed 1.5°C Paris Target

Mysterious Forested Island Appears and Vanishes in Canadian Lake

Scientists Report Potential Breakthrough in Search for Dark Matter